We have previously blogged about some of the insurance issues that cancer patients deal with when considering fertility preservation. Many cancer patients and cancer survivors already also come across complications when becoming full-time college students. The Medical Insurance Blog recently compiled a list of articles that cover this complex subject.
When reading these articles, it is important to keep in mind that health insurance policies for students are changing considerably with the implementation of the new health care reform bill, passed this spring. For specific questions, the Disability Legal Resource Center is a great resource and they are hosting a Cancer Rights Conference on October 8 in Los Angeles, California.
A court ruling last week revived the long-running stem cell debate yet again. In 2001, President Bush allowed federal funding for human embryonic stem cell research on cell lines that were developed before 2001. After taking office, President Obama issued an executive order to remove such...
Many people have never heard of the term parthenote, the byproduct of a process called parthenogenesis. Parthenogenesis occurs when an egg becomes activated and starts dividing without sperm. While parthenogenesis happens frequently in many plants and vertebrate animals...
In previous blogs, we discuss some of the currently available techniques in oncofertility, including sperm banking for men and ovarian tissue cryopreservation (OTC) for women. As one of the newer techniques, OTC allows women to have their ovaries removed, cryopreserved, and then reimplanted later....
In preparing for fertility preservation, cancer fighters may worry about the risks of fertility preservation on the health of their future children. Fertility techniques, such as in vitro fertilization (IVF), produced more than a million babies over the past 30 years. As such, it is important to...
Poor cell phones. Having been blamed for everything from plane crashes to malfunctioning hospital equipment and exploding gas stations, it is a surprise that people still use them. Of special interest to the Oncofertility Consortium, cell phones have also been held responsible for causing cancer...
Advances in oncofertility can help preserve the fertility of many cancer patients but women who receive cancer treatment to the pelvis, including radiation and surgery, may lose the ability to carry a child to term. A few weeks ago, we also discussed how radiation to the ovaries and uterus can...
Discovery about zinc’s role may help in future fertility treatments
By Marla Paul
CHICAGO --- Scientists as well as fertility doctors have long tried to figure out what makes a good egg that will produce a healthy embryo. It’s a particularly critical question for fertility doctors deciding which...
The H Foundation is a non-profit organization that raises money to further the fight against cancer. According to Director Julie Jandris, the foundation was started when two Chicago-based entrepreneurs both had “employees pass away from cancer within one month of each other.” A group of community...
The Dana-Farber Cancer Institute, in Boston, Massachusetts uses MyOncofertility.org to explain reproductive options to their patients. The Survivorship Program at Dana-Farber is developing online tools to discuss the fertility concerns that men and women face when being treated for cancer. In order...
Jonny Imerman is a two-time testicular cancer survivor and founder of the cancer advocacy group, Imerman Angels, which connects cancer patients and their caregivers with the one-on-one support of cancer survivors. Last Friday, Jonny visited the Oncofertility Consortium and discussed his motivation...
The contents of the Oncofertility Consortium Blog are for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
965 Wilson Road, Room A626B
East Lansing, MI 48824-1316
Phone: 1 (517) 884 8848
Email: oncofert@msu.edu
NOTICE:
Ownership of this website has been transferred from Northwestern University to Michigan State University. Please note that some site information may be inaccurate while adjustments to reflect this organizational change are made.